Inmune Bio, Inc. - 10-Q Filing
Inmune Bio reports $16.3M in cash and cash equivalents for Q3 2026 ended September 30.
Tickers: $INMB
More Regulatory news
- Marvell Technology, Inc. - 8-K Filing
- VISHAY INTERTECHNOLOGY INC - 8-K Filing
- CENTRUS ENERGY CORP - 8-K Filing
- SAGA COMMUNICATIONS INC - 8-K Filing
- NextBoat Inc. - 8-K Filing
- CIVISTA BANCSHARES, INC. - 8-K Filing
- RF Acquisition Corp II - 10-Q Filing
- ORASURE TECHNOLOGIES INC - 10-Q Filing
- Rocket Companies, Inc. - 8-K Filing
- Applied Aerospace & Defense, Inc. - 10-Q Filing